NuPathe Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $268M

NuPathe General Information

Description

Developer of therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. The company's flagship product is Zeuity a transdermal system patch for the acute treatment of migraine. The company also has developed a pipeline based on its biodegradable implant technology enabling delivery of therapeutic levels of medication over a period of months with a single dose.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 227 Washington Street
  • Suite 200
  • Conshohocken, PA 19428
  • United States
+1 (484)
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • 227 Washington Street
  • Suite 200
  • Conshohocken, PA 19428
  • United States
+1 (484)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NuPathe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 24-Feb-2014 $268M Completed Generating Revenue
10. Merger/Acquisition 18-Dec-2013 Cancelled Generating Revenue
9. Debt - General 30-Jun-2013 Completed
8. Debt - General 31-Mar-2013 Completed
7. PIPE 23-Oct-2012 Completed Generating Revenue
6. Debt - General 14-Jun-2011 Completed Clinical Trials - Phase 3
5. IPO 06-Aug-2010 Completed Clinical Trials - Phase 3
4. Debt - General 23-Apr-2010 Completed Generating Revenue
3. Early Stage VC (Series B) 24-Jul-2008 $33.6M $49.9M Completed Generating Revenue
2. Early Stage VC (Series A) 13-Sep-2006 $15.7M $16.2M Completed Product Development
To view NuPathe’s complete valuation and funding history, request access »

NuPathe Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view NuPathe’s complete cap table history, request access »

NuPathe Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.
Drug Delivery
Conshohocken, PA
14 As of 2012

Durham, NC
 

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NuPathe Competitors (2)

One of NuPathe’s 2 competitors is BioCryst Pharmaceuticals, a Corporation company based in Durham, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioCryst Pharmaceuticals Corporation Durham, NC
Nabriva Therapeutics Formerly VC-backed Dublin, Ireland
You’re viewing 2 of 2 competitors. Get the full list »

NuPathe Patents

NuPathe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014078517-A1 Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device Inactive 14-Nov-2012
WO-2014078517-A8 Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device Inactive 14-Nov-2012
WO-2012071175-A1 User-activated self-contained co-packaged iontophoretic drug delivery system Inactive 23-Nov-2010
CA-2779096-A1 Methods for treating parkinson's disease Inactive 02-Nov-2009
EP-2496080-A1 Methods for treating parkinson's disease Inactive 02-Nov-2009 A61K31/4985
To view NuPathe’s complete patent history, request access »

NuPathe Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NuPathe Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Battelle Ventures Venture Capital Minority
Bay City Capital Venture Capital Minority
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
BioAdvance Capital (Conshohocken) Venture Capital Minority
Birchmere Ventures Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

NuPathe FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process